# CGG Medical Inc – FDA Inspection, Feb 11, 2019

Source: https://www.keypedia.com/records/fda_inspections/cgg-medical-inc/8a722d79-204a-466e-b94d-13dc07e4071e
Source feed: FDA_Inspections

> FDA inspection 1078933 of CGG Medical Inc, February 11, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 1271. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1078933
- Company Name: CGG Medical Inc
- Inspection Date: 2019-02-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1269682 - 2025-04-24
- [FDA Inspection 1147263 - 2021-07-21](https://www.keypedia.com/records/fda_inspections/cgg-medical-inc/5ddc5e5f-d1a3-4abf-9584-3e5cb0e6d190)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/barbara-t-carmichael/4c451805-e327-450d-b2e5-48a40f6232fe)

Company: https://www.keypedia.com/companies/cgg-medical-inc/40a6e751-f818-455e-bd9c-7c1dd3017021

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d